Cargando…

Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants

This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibility were needed before providing any additio...

Descripción completa

Detalles Bibliográficos
Autores principales: Naegeli, Hanspeter, Bresson, Jean‐Louis, Dalmay, Tamas, Dewhurst, Ian Crawford, Epstein, Michelle M, Firbank, Leslie George, Guerche, Philippe, Hejatko, Jan, Moreno, Francisco Javier, Mullins, Ewen, Nogué, Fabien, Rostoks, Nils, Sánchez Serrano, Jose Juan, Savoini, Giovanni, Veromann, Eve, Veronesi, Fabio, Dumont, Antonio Fernandez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801955/
https://www.ncbi.nlm.nih.gov/pubmed/33473251
http://dx.doi.org/10.2903/j.efsa.2021.6350
_version_ 1783635683070443520
author Naegeli, Hanspeter
Bresson, Jean‐Louis
Dalmay, Tamas
Dewhurst, Ian Crawford
Epstein, Michelle M
Firbank, Leslie George
Guerche, Philippe
Hejatko, Jan
Moreno, Francisco Javier
Mullins, Ewen
Nogué, Fabien
Rostoks, Nils
Sánchez Serrano, Jose Juan
Savoini, Giovanni
Veromann, Eve
Veronesi, Fabio
Dumont, Antonio Fernandez
author_facet Naegeli, Hanspeter
Bresson, Jean‐Louis
Dalmay, Tamas
Dewhurst, Ian Crawford
Epstein, Michelle M
Firbank, Leslie George
Guerche, Philippe
Hejatko, Jan
Moreno, Francisco Javier
Mullins, Ewen
Nogué, Fabien
Rostoks, Nils
Sánchez Serrano, Jose Juan
Savoini, Giovanni
Veromann, Eve
Veronesi, Fabio
Dumont, Antonio Fernandez
collection PubMed
description This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibility were needed before providing any additional recommendations in the form of guidance to applicants. Thus, an interim phase was proposed to assess the utility of an enhanced in vitro digestion test, as compared to the classical pepsin resistance test. Historically, resistance to degradation by pepsin using the classical pepsin resistance test has been considered as additional information, in a weight‐of‐evidence approach, for the assessment of allergenicity and toxicity of newly expressed proteins in GM plants. However, more recent evidence does not support this test as a good predictor of allergenic potential for hazard. Furthermore, there is a need for more reliable systems to predict the fate of the proteins in the gastrointestinal tract and how they interact with the relevant human cells. Nevertheless, the classical pepsin resistance test can still provide some information on the physicochemical properties of novel proteins relating to their stability under acidic conditions. But other methods can be used to obtain data on protein's structural and/or functional integrity. It is acknowledged that the classical pepsin resistance test is embedded into international guidelines, e.g. Codex Alimentarius and Regulation (EU) No 503/2013. For future development, a deeper understanding of protein digestion in the gastrointestinal tract could enable the framing of more robust strategies for the safety assessment of proteins. Given the high complexity of the digestion and absorption process of dietary proteins, it is needed to clarify and identify the aspects that could be relevant to assess potential risks of allergenicity and toxicity of proteins. To this end, a series of research questions to be addressed are also formulated in this statement.
format Online
Article
Text
id pubmed-7801955
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78019552021-01-19 Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants Naegeli, Hanspeter Bresson, Jean‐Louis Dalmay, Tamas Dewhurst, Ian Crawford Epstein, Michelle M Firbank, Leslie George Guerche, Philippe Hejatko, Jan Moreno, Francisco Javier Mullins, Ewen Nogué, Fabien Rostoks, Nils Sánchez Serrano, Jose Juan Savoini, Giovanni Veromann, Eve Veronesi, Fabio Dumont, Antonio Fernandez EFSA J Statement This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibility were needed before providing any additional recommendations in the form of guidance to applicants. Thus, an interim phase was proposed to assess the utility of an enhanced in vitro digestion test, as compared to the classical pepsin resistance test. Historically, resistance to degradation by pepsin using the classical pepsin resistance test has been considered as additional information, in a weight‐of‐evidence approach, for the assessment of allergenicity and toxicity of newly expressed proteins in GM plants. However, more recent evidence does not support this test as a good predictor of allergenic potential for hazard. Furthermore, there is a need for more reliable systems to predict the fate of the proteins in the gastrointestinal tract and how they interact with the relevant human cells. Nevertheless, the classical pepsin resistance test can still provide some information on the physicochemical properties of novel proteins relating to their stability under acidic conditions. But other methods can be used to obtain data on protein's structural and/or functional integrity. It is acknowledged that the classical pepsin resistance test is embedded into international guidelines, e.g. Codex Alimentarius and Regulation (EU) No 503/2013. For future development, a deeper understanding of protein digestion in the gastrointestinal tract could enable the framing of more robust strategies for the safety assessment of proteins. Given the high complexity of the digestion and absorption process of dietary proteins, it is needed to clarify and identify the aspects that could be relevant to assess potential risks of allergenicity and toxicity of proteins. To this end, a series of research questions to be addressed are also formulated in this statement. John Wiley and Sons Inc. 2021-01-12 /pmc/articles/PMC7801955/ /pubmed/33473251 http://dx.doi.org/10.2903/j.efsa.2021.6350 Text en © 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made.
spellingShingle Statement
Naegeli, Hanspeter
Bresson, Jean‐Louis
Dalmay, Tamas
Dewhurst, Ian Crawford
Epstein, Michelle M
Firbank, Leslie George
Guerche, Philippe
Hejatko, Jan
Moreno, Francisco Javier
Mullins, Ewen
Nogué, Fabien
Rostoks, Nils
Sánchez Serrano, Jose Juan
Savoini, Giovanni
Veromann, Eve
Veronesi, Fabio
Dumont, Antonio Fernandez
Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
title Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
title_full Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
title_fullStr Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
title_full_unstemmed Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
title_short Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
title_sort statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
topic Statement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801955/
https://www.ncbi.nlm.nih.gov/pubmed/33473251
http://dx.doi.org/10.2903/j.efsa.2021.6350
work_keys_str_mv AT statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT naegelihanspeter statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT bressonjeanlouis statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT dalmaytamas statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT dewhurstiancrawford statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT epsteinmichellem statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT firbanklesliegeorge statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT guerchephilippe statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT hejatkojan statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT morenofranciscojavier statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT mullinsewen statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT noguefabien statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT rostoksnils statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT sanchezserranojosejuan statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT savoinigiovanni statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT veromanneve statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT veronesifabio statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants
AT dumontantoniofernandez statementoninvitroproteindigestibilitytestsinallergenicityandproteinsafetyassessmentofgeneticallymodifiedplants